GlassScriptPhysician profile
Tuong Cat Vo
NPI 1740024769
$817.92
in general payments reported to CMS, 2019-2025
9 companies · $818 in 2025
The $818 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $817.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $189.98 | 2025 | Omnipod, Omnipod |
| Astrazeneca Pharmaceuticals LP | $150.33 | 2025 | Airsupra, Breztri |
| Lilly USA, LLC | $120.38 | 2025 | Jardiance |
| Novo Nordisk INC | $117.22 | 2025 | Ozempic |
| Corcept Therapeutics | $101.66 | 2025 | Korlym |
| Cequr Corporation | $70.50 | 2025 | Cequr Simplicity |
| Sequel Med Tech, LLC | $29.23 | 2025 | Twiist |
| Pfizer INC. | $20.47 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.15 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tuong Vo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.